Skip to main content
. 2018 Apr 12;48(6):542–547. doi: 10.1093/jjco/hyy038

Table 4.

List of adverse events with incidence of ≥5%

PTa Hydromorphone group N = 88 n (%) Oxycodone group N = 84 n (%) Total N = 172 n (%)
Number of patients with adverse event 73 (83.0) 65 (77.4) 138 (80.2)
 Somnolence 23 (26.1) 21 (25.0) 44 (25.6)
 Constipation 21 (23.9) 19 (22.6) 40 (23.3)
 Vomiting 17 (19.3) 15 (17.9) 32 (18.6)
 Nausea 14 (15.9) 14 (16.7) 28 (16.3)
 Diarrhea 12 (13.6) 9 (10.7) 21 (12.2)
 Delirium 2 (2.3) 5 (6.0) 7 (4.1)

aMedDRA V.16.1 Preferred Term (PT).